FDA Approves Treatment for ALS Patients

 The Angel Fund supports the research of Dr. Robert H. Brown, Jr., world renowned ALS researcher. Dr. Brown is the Chair and professor of Neurology at UMass Medical School. Dr. Robert H. Brown, Jr. and the UMass Gene Therapy Center team are working on this exciting cutting-edge research using gene therapy to silence ALS genes.

Watch what Dr. Brown has to say about the progress of ALS research.

Great news for ALS patients – FDA approves treatment for new drug !

Radicava (edaravone) has been approved by the FDA and will be available to treat ALS patients. MT Pharma America has been granted to begin marketing edaravone as a treatment for ALS. This is the first ALS treatment to be approved since 1995!!

 

 

 

No Comments Yet.

Leave Your Comment